Sou Hu Cai Jing·2025-12-02 12:34Core Viewpoint - The stock of Chunli Medical (688236) has shown a decline in price and mixed capital flow, indicating potential volatility in investor sentiment and market performance [1][2]. Financial Performance - As of December 2, 2025, Chunli Medical's stock closed at 24.31 yuan, down 0.86% with a trading volume of 9,241 hands and a transaction value of 22.5152 million yuan [1]. - In the last five days, the stock experienced fluctuations in capital flow, with a net outflow of 218.06 million yuan from main funds on December 2, 2025, while retail investors saw a net outflow of 140.51 million yuan [2]. - For the first three quarters of 2025, Chunli Medical reported a main revenue of 756 million yuan, a year-on-year increase of 48.75%, and a net profit of 192 million yuan, up 213.21% year-on-year [3]. Industry Comparison - Chunli Medical's total market value is 9.325 billion yuan, which is below the industry average of 11.042 billion yuan, ranking 38 out of 124 in the medical device sector [3]. - The company has a gross margin of 67.27%, significantly higher than the industry average of 51.22%, and a net profit margin of 25.34%, compared to the industry average of 9.57% [3]. Analyst Ratings - In the past 90 days, 8 institutions have rated Chunli Medical, with 7 buy ratings and 1 hold rating, indicating a generally positive outlook among analysts [4]. - The average target price set by institutions for the stock is 31.8 yuan, suggesting potential upside from the current trading price [4].